共 47 条
[1]
Oldfield LE(2017)Molecular events in the natural history of pancreatic cancer Trends Cancer 3 336-346
[2]
Connor AA(2019)Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives Cancer Treat Rev 72 1-6
[3]
Gallinger S(2007)National failure to operate on early stage pancreatic cancer Ann Surg 246 173-180
[4]
Macchini M(2006)Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 1035-1046
[5]
Chiaravalli M(2016)Potentially curable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline J Clin Oncol 34 2541-2556
[6]
Zanon S(2011)An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivar Behav Res 46 399-424
[7]
Bilimoria KY(2017)Survival analysis in the presence of competing risks Ann Transl Med 5 47-132
[8]
Bentrem DJ(2017)Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: an analysis of 18 243 patients J Surg Oncol 116 127-1825
[9]
Ko CY(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-958
[10]
Varadhachary GR(2017)Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients World J Surg Oncol 15 183-794